Some of the major industry players motivated to persistently capture better markets and enter new ones are Abbott Laboratories, Boston Scientific Corporation, Cook Medical Inc., MicroPort Scientific Corporation (Endovastec), Medtronic Plc.
Luton, Bedfordshire, United Kingdom, Dec. 07, 2022 (GLOBE NEWSWIRE) — Exactitude Consultancy, the market research and consulting arm of Ameliorate Digital Consultancy Private Limited has completed and published the final copy of the detailed research report on the Peripheral Vascular Devices. Market.
The global peripheral vascular devices market is expected to grow at a CAGR of 6% from 2022 to 2029. It is expected to reach over USD 17.74 billion by 2029 from USD 10.5 billion in 2020.
Peripheral Vascular Devices Market Overview
The peripheral vascular involves damage or blockage in the blood vessels away from your heart – the peripheral arteries and veins. When the peripheral vascular disease affects only the arteries and not the veins, it is called peripheral arterial disease. The main forms that peripheral vascular disease can take include blood clots (for example, deep vein thrombosis or DVT), swelling (inflammation), or narrowing and blockage of the blood vessels.
Patients with PAD are at high risk of having a heart attack. To treat blocked arteries, angioplasty procedures are performed, in which peripheral vascular devices are placed in the arteries after vascular surgery or angioplasty to prevent the artery from closing again, thus aiding in the maintenance of blood flow by providing structural support to the artery.
Increased emphasis on the prevention and treatment of peripheral arterial disease in low- and middle-income economies is expected to drive the growth of the peripheral vascular devices market. The rising prevalence of peripheral artery disease is fueling the demand and focus on interventional cardiology. As the first line of treatment for patients with long-standing cardiovascular diseases, angioplasty is performed.
The increase in the number of cases of peripheral arterial disease is contributing to the expansion of the market for peripheral vascular devices.
Live Get Free Sample Report of Peripheral Vascular Devices Market ->
https://exactitudeconsultancy.com/reports/5615/peripheral-vascular-devices-market/#request-a-sample
Growth Factors
Retentions
-
Infection as a result of peripheral vascular implants
-
In institutional settings, the material cost composition of peripheral vascular devices is higher.
-
The high cost of implementing these devices
Peripheral Vascular Devices Market Segmentation
By Product
-
Peripheral Vascular Stents: Peripheral vascular stents is expected to exhibit high growth at a CAGR of 6.0% by the end of the forecast period.
-
Self-Expanding Stents
-
Balloon Expanding Stents
-
Covered Stents
-
-
Drug-Eluting Stents
-
Balloons for Drug Elution
-
Peripheral Vascular Bioresorbable Scaffolds
By Indications
-
Target Arterial Instability (TAI)
-
Access Artery Injury (AAI)
-
Peripheral Arterial Disease: Peripheral artery disease has a revenue of 30.3% in the global market in 202.1
-
Arteriovenous Fistulas
-
Peripheral aneurysms
-
Others
By Artery
-
Carotid Artery
-
Fem-Pop Artery
-
lalia Artery
-
Infrapop Artery
In 2021, the iliac artery will have a global revenue of about 48.1%. Claudication and/or critical limb ischaemia are mainly caused by aortoiliac disease, which has a general population prevalence of up to 10% and a prevalence of up to 20% in people over 70 years of age. Aortoiliac occlusive disease is a type of peripheral artery disease. disease
By End User
Read Full Report->
https://exactitudeconsultancy.com/reports/5615/peripheral-vascular-devices-market/
Hospitals will have a market share of approximately 60.4% in 2021. The increasing prevalence of chronic and infectious diseases, as well as the associated increase in surgical procedures, have propelled this segment to the forefront of the peripheral vascular devices market.
Regional Insights
The United States dominates the North American region with a total market share of approximately 94.5% in 2021, and this growth is expected to continue during the forecast period.
China holds approximately 56.5% of the East Asia market in 2021 and is expected to grow at 8.5% CAGR during the forecast period.
During the forecast period, Germany is expected to exhibit a CAGR of nearly 6.0% in the European peripheral vascular devices market. The large geriatric population, advanced medical device technology and research, and a high prevalence of chronic diseases all contribute to market expansion in Germany.
The Latin American Peripheral Vascular Devices Market is expected to grow at a CAGR of 7.93% from 2021 to 2026. The growing elderly population, which is associated with an increase in the prevalence of peripheral vascular disorders, the approval of new and improved devices, and the increasing incidence of diabetes all drive this industry forward in Latin America.
Competitive Landscape
Companies are playing a promising role in the global peripheral vascular devices market profiled in the report Abbott Laboratories, Boston Scientific Corporation, Cook Medical Inc., MicroPort Scientific Corporation (Endovastec™), Medtronic Plc., Cardinal Health, Inc., B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Becton, Dickinson and Company, WL Gore & Associates Inc., Getinge AB, Terumo Corp, Kyoto Medical Planning Co Ltd, iVascular SLU, AMG International GmbH, ENDOCOR GmbH, Meril Life Sciences Pvt. Ltd., Nano Therapeutics Pvt Ltd, Koninklijke Philips NV, REVA Medical
-
28 April 2022 – Boston Scientific Corporation has received 510(k) clearance from the US Food and Drug Administration (FDA) for the EMBOLD Fiber Removable Coil, which is indicated to prevent or decrease the rate of blood flow in the peripheral vasculature.
-
18 August 2022: BD Launches First-in-Human Trial of Sirolimus Drug-Coated Balloon to Expand Treatment Options for Peripheral Artery Disease
-
September 17, 2022 – Terumo Medical Corporation, a subsidiary of Terumo Corporation, a leading global medical device manufacturer, announces late data showing the safety and efficacy of radial to Peripheral (R2P) interventions with the R2P Misago Self-Expanding Peripheral Stent in lower extremity endovascular interventions. by radial approach.
-
In June 2022Cardio Flow, Inc., a medical device company and manufacturer of minimally invasive peripheral vascular devices to treat peripheral artery disease (PAD), announced approval by the US Food and Drug Administration (FDA) for the company’s FreedomFlow Peripheral Guidewire.
-
June 02, 2022Cardio Flow, Inc., a medical device company and developer of minimally invasive peripheral vascular devices to treat peripheral artery disease (PAD), announced that it recently received clearance from the US Food and Drug Administration (FDA) for the FreedomFlow® Peripheral Guidewire from the company.
Related Reports
-
Interventional Radiology Product Market
-
Interventional Cardiology Devices Market
-
Vascular Access Device Market
-
Catheters Market
-
Microcatheters Market
Frequently Asked Questions
-
What is the growth rate of Global Peripheral Vascular Devices market?
-
Which region has the highest growth in Global Peripheral Vascular Devices Market?
-
Who are the leading market players in the Global Peripheral Vascular Devices Market?
-
What are the growth factors of Peripheral Vascular Devices Market?
-
Which segments are covered in the Peripheral Vascular Devices Market?
Related Reports:-
Blood Collection Devices Market
Blood collection devices market size was valued at USD 5.2 billion in 2020 and is projected to reach USD 8.78 billion by 2029, growing at a CAGR of 6% from 2022 to 2029.
https://exactitudeconsultancy.com/reports/11880/blood-collection-devices-market/
Body Area Network Market
Body area market size was estimated at USD 10.32 billion in 2020 and is projected to reach USD 23.93 billion by 2029, growing at a CAGR of 9.8% from 2022 to 2029.
https://exactitudeconsultancy.com/reports/11838/body-area-network-market/
Aesthetic Lasers Market
The global aesthetic laser market is expected to grow at a CAGR of 6.97% from 2022 to 2029. It is expected to reach over USD 18.78 million by 2029 from USD 10.24 million in 2020.
https://exactitudeconsultancy.com/reports/11173/aesthetic-lasers-market/
Healthcare Mobility Solutions Market
The global mobile healthcare solutions market is expected to grow at a CAGR of 28% from 2022 to 2029. It is expected to reach over USD 581 billion by 2029 from USD 63 billion in 2020.
https://exactitudeconsultancy.com/reports/11110/healthcare-mobility-solutions-market/
Bone Growth Stimulators Market
Bone growth stimulators market size was valued at USD 1.13 billion in 2020 and is projected to reach USD 1.88 billion by 2029, growing at a CAGR of 5.8% from 2022 to 2029.
https://exactitudeconsultancy.com/reports/11066/bone-growth-stimulator-market/
CONTACT: Contact us -> Irfan Tamboli (Head of Sales) - Exactitudeconsultancy Phone: + 1704 266 3234 [email protected]
